20/21 February 2024
Munich, Germany
The "Access Consortium", a consortium of the regulatory authorities from Australia (TGA), Canada (HBFB), Switzerland (Swissmedic), Singapore (HSA) and now also the United Kingdom (MHRA), published a three-year plan in the summer of 2021 regarding planned common approaches and goals.
This joint body has existed since 2007, initially under the name "ACSS". In 2020, the MHRA initially joined as a so-called "observer" and has been a full member of the consortium since January 2021. The international association of authorities is intended to support a uniform regulatory and more efficient approach and to strengthen cooperation in the area of approval.
The representatives of the authorities have now drawn up and published an "Access Strategic Plan". It lists the tasks and strategic goals of the consortium for the years 2021 to 2024 and also presents the challenges, also against the background of the Covid-19 pandemic.
The following points identify the three main goals of the plan:
Here you can find the complete "Access Strategic Plan" and further information on the "Access Consortium".